Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25-dihydroxyvitamin D

David M. Slovik(Boston University), Robert M. Neer(Brigham and Women's Hospital), Samuel H. Doppelt(Harvard University), John T. Potts(National Institutes of Health), Margaret A. Daly(Harvard University), Julie A. Campbell(Harvard University), Daniel I. Rosenthal(Massachusetts General Hospital)
Journal of Bone and Mineral Research
August 1, 1986
10.1002/jbmr.5650010411
Cited by 349

Related Papers

Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.
|BMJ|1980|585
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
|The Lancet|2015|574
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
|The Lancet|2013|491
Deficient Production of 1,25-Dihydroxyvitamin D in Elderly Osteoporotic Patients
|New England Journal of Medicine|1981|372
Decreased Bone Density in Hyperprolactinemic Women
|New England Journal of Medicine|1980|363